Inhibition of the human mitochondrial ClpP protease as a novel strategy against multiple myeloma

被引：0

作者：

Patrone, M. ^{[1
]}

Di Pisa, F. ^{[1
]}

Tosatto, L. ^{[2
]}

Swuec, P. ^{[2
]}

Perini, T. ^{[1
]}

Resnati, M. ^{[1
]}

Del Grosso, Erika ^{[3
]}

Yudin, A. K. ^{[4
]}

Schimmer, A. D. ^{[5
]}

Cenci, S. ^{[1
]}

Coscia, F. ^{[2
]}

Degano, M. ^{[1
]}

机构：

[1] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy

[2] Human Technopole, Viale Rita Levi Montalcini 1, I-20157 Milan, Italy

[3] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Lgo Donegani 2, I-28100 Novara, Italy

[4] Univ Toronto, Dept Chem, Davenport Res Labs, 80 St George St, Toronto, ON M5S 3H6, Canada

[5] Univ Hlth Network, Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G 2M9, Canada

来源：

ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[21] Gck Inhibition Is a Novel Therapeutic Strategy for RAS Mutated Multiple Myeloma and Overcomes Resistance to IMiDs
Li, Shirong
Fu, Jing
Yang, Jun
Mapara, Markus Y.
Marcireau, Christophe
Lentzsch, Suzanne
BLOOD, 2020, 136
[22] Inhibition of human multiple myeloma proliferation by naltrindole
Joshi, Jyoti
Terskiy, Alexandra
Howells, Richard D.
CANCER RESEARCH, 2011, 71
[23] Novel compounds directed against the inhibition of protease cascades
Edwards, Paul
DRUG DISCOVERY TODAY, 2007, 12 (23-24) : 1083 - 1084
[24] Inhibiting Translation as a Novel Strategy to Target Multiple Myeloma
Roman, William
Cencic, Regina
Huang, Xiang-Fang
Porco, John
Pelletier, Jerry
Shustik, Chaim
Sebag, Michael
BLOOD, 2010, 116 (21) : 1235 - 1235
[25] Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Engelhardt, Monika
Waldschmidt, Johannes Moritz
Waesch, Ralph
HAEMATOLOGICA, 2022, 107 (05) : 1018 - 1019
[26] RNA Polymerase I Inhibition with CX-5461 As a Novel Strategy to Target MYC in Multiple Myeloma
Lee, Hans
Wang, Hua
Lin, Heather
Baladandayuthapani, Veera
He, Jin
Jones, Richard Julian
Kuiatse, Isere
Gu, Dongmin
Wang, Zhiqiang
O'Brien, Sean
Keats, Jonathan J.
Yang, Jing
Davis, Richard Eric
Orlowski, Robert Z.
BLOOD, 2015, 126 (23)
[27] Sumoylation Inhibition Potentiates Daratumumab Activity Against Multiple Myeloma
Du, Li
Liu, Wei
Caserta, Enrico
Pichiorri, Flavia
Rosen, Steve T.
BLOOD, 2022, 140 : 9972 - 9973
[28] Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma
Li, Shirong
Fu, Jing
Yang, Jun
Ma, Huihui
Bhutani, Divaya
Mapara, Markus Y.
Marcireau, Christophe
Lentzsch, Suzanne
BLOOD, 2021, 137 (13) : 1754 - 1764
[29] The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma
Maneix, Laure
Sweeney, Melanie A.
Lee, Sukyeong
Iakova, Polina
Moree, Shannon E.
Sahin, Ergun
Lulla, Premal
Yellapragada, Sarvari V.
Tsai, Francis T. F.
Catic, Andre
CANCERS, 2021, 13 (04) : 1 - 19
[30] Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
Tai, Yu-Tzu
Chang, Betty Y.
Kong, Sun-Young
Fulciniti, Mariateresa
Yang, Guang
Calle, Yolanda
Hu, Yiguo
Lin, Jianhong
Zhao, Jian-Jun
Cagnetta, Antonia
Cea, Michele
Sellitto, Michael A.
Zhong, Mike Y.
Wang, Qiuju
Acharya, Chirag
Carrasco, Daniel R.
Buggy, Joseph J.
Elias, Laurence
Treon, Steven P.
Matsui, William
Richardson, Paul
Munshi, Nikhil C.
Anderson, Kenneth C.
BLOOD, 2012, 120 (09) : 1877 - 1887

← 1 2 3 4 5 →